PAVMED INC. (NASDAQ:PAVM) Files An 8-K Results of Operations and Financial Condition

PAVMED INC. (NASDAQ:PAVM) Files An 8-K Results of Operations and Financial Condition
Item 2.02.

(d) Exhibits:
Exhibit No. Description
99.1 Press release.


PAVmed Inc. Exhibit
EX-99.1 2 ex99-1.htm   Exhibit 99.1     PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results   Announces majority-owned subsidiary Lucid Diagnostics intends to spin-off into a separate public company   Lucid Diagnostics to launch major new multi-channel commercialization initiative for its EsoGuard Esophageal DNA Test   Conference call to be held today at 8:30 AM EST   NEW YORK,…
To view the full exhibit click here

An ad to help with our costs